Loading drug development pipeline…
Loading drug development pipeline…
Derived
For each drug, the most advanced stage supported by registered interventional trials and jurisdiction-aware approval records. Approval in any ingested jurisdiction outranks trial phase; a drug is counted once, at its highest stage.
Computedci-drug-pipeline-v1Stage rulesApprovals feed →
Funnel
Drugs reach Malignant Breast Neoplasm through trial conditions or approval indications mapped to it or to one of its descendant entities.
48 drugs · 217 active trials
17 drugs · 330 active trials
43 drugs · 1,254 active trials
Outside the funnel: Phase not stated 1. "Withdrawn" = every approval record for the scope is withdrawn or superseded; "phase not stated" = trials exist but none states a phase.
Data updated 6 hours agoSource updated unknownrecomputed with the intelligence layer
Drugs
Most advanced stage first, then most active trials. Trial counts are interventional studies linking the drug (and, when a cancer is selected, the cancer).
| Drug | Stage | Max phase | Active | Recruiting | Phase 3 | Total trials | Approvals | Jurisdictions | First approval | First trial |
|---|---|---|---|---|---|---|---|---|---|---|
| Carboplatin | Phase 4 | Phase 4 | 88 | 40 | 47 | 267 | 0 | — | — | 1991-11 |
| Cyclophosphamide | Phase 4 | Phase 4 | 79 | 41 | 135 | 456 | 0 | — | — | 1989-05 |
| Nab-paclitaxel | Phase 4 | Phase 4 | 51 | 24 | 32 | 151 | 0 | — | — | Jun 1, 2004 |
| Pyrotinib | Phase 4 | Phase 4 | 29 | 13 | 9 | 58 | 0 | — | — | 2013-01 |
| Bevacizumab | Phase 4 | Phase 4 | 20 | 16 | 22 | 158 | 0 | — | — | 2000-11 |
| Chemotherapy | Phase 4 | Phase 4 | 20 | 9 | 15 | 50 | 0 | — | — | 1999-01 |
| Toripalimab | Phase 4 | Phase 4 | 13 | 10 | 1 | 19 | 0 | — | — | Dec 21, 2018 |
| Aromatase Inhibitor | Phase 4 | Phase 4 | 11 | 5 | 2 | 22 | 0 | — | — | Nov 7, 2008 |
| Pegfilgrastim | Phase 4 | Phase 4 | 5 | 2 | 13 | 52 | 0 | — | — | 2001-10 |
| Dexamethasone | Phase 4 | Phase 4 | 5 | 3 | 5 | 23 | 0 | — | — | 2004-08 |
| Carboplatin/Paclitaxel Regimen | Phase 4 | Phase 4 | 4 | 1 | 2 | 8 | 0 | — | — | 2007-12 |
| Lenvatinib | Phase 4 | Phase 4 | 3 | 0 | 0 | 9 | 0 | — | — | 2016-12 |
| Filgrastim | Phase 4 | Phase 4 | 1 | 1 | 12 | 72 | 0 | — | — | 1991-11 |
| Sunitinib | Phase 4 | Phase 4 | 1 | 0 | 0 | 15 | 0 | — | — | Mar 1, 2006 |
| Zoledronic Acid | Phase 4 | Phase 4 | 0 | 0 | 24 | 46 | 0 | — | — | 1999-06 |
| Pazopanib | Phase 4 | Phase 4 | 0 | 0 | 0 | 10 | 0 | — | — | 2007-01 |
| Paclitaxel Liposome | Phase 4 | Phase 4 | 0 | 0 | 0 | 1 | 0 | — | — | 2014-05 |
Stages describe registered activity and ingested regulatory records, not efficacy. Only ingested jurisdictions (currently US and Canada) can place a drug at "approved"; trial phases are as registered by sponsors. Nothing here is a treatment recommendation.